Cargando…
r.hu-Erythropoietin (EPO) treatment of pre-ESRD patients slows the rate of progression of renal decline
BACKGROUND: As EPO treatment of chronic anemia of advanced renal disease is now the standard of care we examined if such treatment may slow the progression of renal function decline. METHODS: Data of 18 pre-ESRD patients were analyzed retrospectively 12 months prior and prospectively 12 months after...
| Autores principales: | , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2003
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC165597/ https://www.ncbi.nlm.nih.gov/pubmed/12809563 http://dx.doi.org/10.1186/1471-2369-4-3 |